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ABSTRACT
Canine parvovirus (CPV) is an important pathogen causing acute hemorrhagic gastroenteritis in dogs 
and myocarditis in pups. The present study deals with an analysis of partial nucleotide sequences of the VP1/
VP2 gene of CPV isolates from Mathura, India to establish their phylogenetic relationship with other CPV 
isolates. Out of 100 samples from dogs showing the clinical signs of gastroenteritis viz., vomiting, diarrhea 
and dysentery, 63 were found positive for CPV-2 by polymerase chain reaction (PCR). Among the 63 positive 
samples, eight samples were processed further for nucleotide sequencing. Phylogenetic analysis revealed that 
the CPV variants were not only closely related among themselves but also showed minimum divergence from 
their ancestors, such as MEV, indicating very little divergence since their origin. From the study, it may be 
concluded that canine parvovirus-2 variants may represent a potential threat to canine populations. Thus more 
efforts is required to increase epidemiological monitoring and surveillance, along with the measures necessary 
to control this disease in the canine population, and to assess the effi cacy of the current vaccines. 
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Introduction 
Canine parvovirus (CPV) was fi rst identifi ed in 1978 (SINGH et al., 2013). Since then it 
has spread very quickly and has become endemic in most parts of the world (GUY, 1986). 
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The virus has a genome consisting of single stranded DNA of 5.2 kbp length. It causes a 
highly contagious disease that can spread rapidly through a population of dogs with high 
morbidity (100%) and frequent mortality up to 10% (APPEL et al., 1978; SINGH et al., 2013). 
The virus has two different strains i.e. CPV-1 and CPV-2. With a high evolution rate, three 
CPV-2 variations have emerged since its fi rst isolation (SHACKELTON et al., 2005). CPV-2 
variations emerged in 1980 in the United States (PARRISH et al., 1988). CPV-2b replaced 
CPV-2a in many regions of the US after 1986 (PARRISH et al., 1991). In 2001, CPV-2c 
was fi rst reported in Italy and then in some other countries, including the USA and Brazil 
(HONG et al., 2007; PERVEZ et al., 2007), Vietnam (NAKAMURA et al., 2003) and India 
(NANDI et al., 2010). In India, CPV-2 was fi rst reported in 1982 by Ramadass and Khader 
and since then has been a major concern of animal health professionals. To date a large 
number of outbreaks have been reported from different parts of India in dogs involving 
different variants of CPV viz., 2a, 2b and 2c (CHINEHKAR et al., 2006; BISWAS et al., 2006; 
NANDI et al., 2009a and 2009b). The Polymerase Chain Reaction (PCR) technique has been 
widely applied for early and confi rmatory laboratory diagnosis of the disease, due to its 
high sensitivity and specifi city (SCHUNCK et al., 1995; NANDI et al., 2006, 2008 and 2010; 
SINGH et al., 2013). 
However, scanty literature is available on the antigenic and genetic characterization of 
CPV isolates from India. Thus, the present study was envisaged to genetically characterize 
CPV isolates from Mathura, India and to compare them with other published CPV strains.
Materials and methods
Study design, area, fecal sample preparation. During the present study, a total of 100 
fecal samples were collected from dogs, presented to the Teaching Veterinary Clinical 
Complex, DUVASU, Mathura, India and showing clinical signs of gastroenteritis. The 
fecal samples were collected in the form of a rectal swab, using pre-sterilized swabs, and 
immediately transferred in a ratio of 1:9 to labeled sterile vials with Hank’s balanced salt 
solution (HBBS) containing streptomycin (100 mg/L) and penicillin (1 Lakh IU/L). The 
swabs were properly rinsed in the HBSS vials and taken out. The remaining fecal contents 
in the HBSS were centrifuged at 10,000 rpm at 4 oC for 3 min in a refrigerated centrifuge. 
The supernatants were pipetted out and fi ltered through a disposable syringe fi lter (0.45 
μm). Inactivated canine nasal parvo vaccine, supplied by Indian Immunological Limited, 
Hyderabad, was used as a positive control of CPV and a stool sample from a healthy dog, 
processed in the same way, was used as a negative control.
Genomic DNA extraction and PCR amplifi cation of CPV-2. The genomic DNA from 
the fecal samples was extracted by the phenol chloroform method (SAMBROOK and 
RUSSEL, 2001). To remove inhibitory substances, 200 μL of sample was treated with 
sodium dodecyl sulphate (SDS) and proteinase K, with a fi nal concentration of 1% and 
250 μg/ ml, and kept at 56 oC for 30 minutes in a water bath. Then, 200 μL of Tris 
saturated phenol, chloroform and isoamyl alcohol (25:24:1) was added to 200 μL of the 
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sample in an Eppendorf tube and mixed thoroughly. It was centrifuged at 10,000 rpm for 
5 min at 4 ºC and the supernatant was collected in another Eppendorf tube. Then 1/10th 
volume of 3M sodium acetate (pH 5.5) and 1 mL of chilled ethanol was added, mixed and 
kept at -20 ºC overnight. After that the tubes were centrifuged at 12,000 rpm for 15 min 
at 4 ºC. The supernatant was discarded and pellets washed with 500 μL of 70% ethanol, 
followed by centrifugation at 12,000 rpm for 2 min. The ethanol was discarded and the 
pellets dried at 37 °C and re-suspended in 20 μL of nuclease free water. The purity of 
DNA was checked by UV-spectrophotometer by taking 260/280 nm ratio, which was 
found to be between 1.7 to 1.8 and the concentration of DNA was 20 ng/μl. 
The set of primer {pCPV forward primer-5’ GAA GAG TGG TTG TAA ATA ATT-
3’ (21 mer) and pCPV reverse primer-5’-CCT ATA TCA CCA AAG TTA GTA G-3’ 
(22mer)}, used to amplify the partial VP1/VP2 gene of the CPV in PCR, was custom 
designed to yield an amplicon of 681bp (PEREIRA et al., 2000). PCR was performed in 
0.2 mL PCR tubes (Eppendorf) with a reaction volume of 50 μL. The reaction mixture 
contained 200 μM dNTPs, 10 pmol of each primer, 5 μL of 10x Taq DNA polymerase 
buffer containing 15 mM MgCl2, 5 μL of extracted DNA as template and 1 μL of Hotstar 
DNA polymerase (1 IU/ μL) and nuclease free water to make the volume up to 50 μL. 
The cycling conditions comprised: initial denaturation at 95 °C for 5 min, followed by 
30 cycles of denaturation at 94 °C for 30 sec, primer annealing at 55 °C for 2 min, and 
extension at 72 °C for 30 sec. Then, the fi nal extension was done at 72 °C for 10 min. 
After completion of PCR, the amplifi ed products were electrophoresed on 1% agarose 
gel, stained with ethidium bromide and then visualized under the UV transilluminator. 
The PCR products were purifi ed from the gel using a gel extraction kit (Genei Pvt Ltd., 
Banglore) as per the manufacturer’s protocol, and then sequenced.
Phylogenetic analysis. For phylogenetic analysis of these recent isolates with the rest 
of the previous isolates included in the tree construction, the sequences were retrieved 
from the GenBank. Molecular sequences (nucleotide and amino acids) were aligned 
against the other published CPV VP1/VP2 gene sequences using the clustal W/X algorithm 
(THOMPSON et al., 1994 and 1997), implemented in the OMIGA 2.0 program (Oxford 
Molecular Ltd, UK) and refi ned in clustal X (THOMPSON et al., 1997). Phylogenetic and 
molecular evolutionary analyses were conducted using MEGA version 4 (TAMURA et 
al., 2007). The TAMURA and NEI (1993) model of nucleotide substitution with gamma-
distribution of among site rate heterogeneity (with 8 categories) (termed as TrN + G 
model) available in MEGA was used to construct the trees. The tree topologies were 
evaluated using 10,000 replicates of the data set. The tree thus generated was produced in 
Lotus Freelance Graphics 97. 
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Results
In the present study, a total of 100 samples were tested, out of which an amplicon of 
681bp was obtained in 63 samples showing the presence of canine parvovirus infection 
in these dogs. The positive control also showed similar amplifi cation of DNA, while in 
the negative control no such amplifi cation was visualized on an agarose gel. Nucleotide 
sequences were aligned, phylogenetically characterized and compared with various 
previous isolates CPV-2 isolates, mink enteritis virus-1 and 2 (MEV-1 and 2) available on 
the NCBI and CPV-2 vaccine, with the help of MegAlign software. In the Phylogenetic 
tree (Fig. 1), all the fi eld isolates isolated in the present study were grouped in one group, 
along with isolates from China, Brazil, Bareilly, Kerala-2 and the vaccine strain indicating 
the similarity between them. However, the isolates (Pondicherry 1 and 2; Kerala-1) could 
be distributed in another genetic group.
The nucleotide (nt) divergence among the fi eld isolates (Mathura 1-8) sequenced in 
this study and vaccine strains and other representative isolates (MEV-1, CPV-2a, CPV-2b 
Pondichery, CPV-2b China, CPV-2b Bareilly, CPV-2b Brazil, CPV-2b Iyrland, CPV-2b 
Pondichery-2, CPV-2b Kerala) is shown in Table 1. From the table it can be seen that 
the nucleotide divergence between Mathura isolates and CPV-2b Pondichery-2 isolates 
is higher (5.8%) compared to that among the recent fi eld isolates from Mathura (0.00%). 
Alignment of partial nucleotide sequences of the VP1/VP2 region revealed common 
substitution in the recent fi eld isolates, in comparison with MEV. These differences were 
found at various synonymous positions (nt 2 T—A, 12 A—T, 42 A—C, 99 T—C, 108 
A—G, 555 A—C, 591 T—C, 623 A—G, 635 C—G, 654 A—G) compared to the MEV.
Table 1. Percentage divergence of partial nucleotide sequences of VP1/VP2 gene of CPV isolates
1 2 3 4 5 6 7 8 9 10 11
MEV 1 1
CPV 2a 2 0.9 
CPV 2b Pondicherry 3 3.7 2.8 
CPV 2b China 4 0.9 1.8 2.8 
CPV 2b Vaccine 5 0.9 1.8 2.8 0.00 
CPV 2b Bareilly 6 0.9 1.8 2.8 0.00 0.00 
CPV 2b Mathura 7 0.9 1.8 2.8 0.00 0.00 0.00 
CPV-2b Brazil 8 0.9 1.8 2.8 0.00 0.00 0.00 0.00 
CPV 2b Ireland 9 1.9 2.8 3.8 0.9 0.9 0.9 0.9 0.9 
CPV 2b Pondichery2 10 6.9 5.8 6.9 5.8 5.8 5.8 5.8 5.8 6.9 
CPV 2b Kerala 11 1.9 2.8 3.8 0.9 0.9 0.9 0.9 0.9 1.9 4.8 
509Vet. arhiv 84 (5), 505-512, 2014
D. Singh et al.: Phylogenetic analysis of CPV in India
Fig. 1. Neighbor joining tree constructed from VP1/VP2 gene sequences showing the 
phylogenetic relationships between CPV isolates. (Horizontal branch lengths are drawn to scale)
Discussion
Phylogenetic analysis also revealed that CPV variants are not only closely related 
among themselves, but also show minimum divergence from their ancestors, such as 
MEV, indicating very little divergence since it was fi rst identifi ed in 1978 (APPEL et al., 
1978). There was no appreciable variation within the various isolates. The variations that 
were observed nevertheless played a crucial role in the evolution of different variants 
in several geographical regions of the world. NANDI et al. (2009a) also reported 1.7% 
divergence of IVRI CPV-2b isolates from the Brazil CPV-2a isolate. They further reported 
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that IVRI isolates closely resembled an Italian strain. Various researchers (PARRISH et 
al., 1991; STEINEL et al., 1998; NANDI et al., 2009a and 2009b) reported that CPV-2a and 
CPV-2b co-existed in different ratios in various countries, indicating no evolutionary 
advantage of one type over another, and this co-existence has not evolved under immuno-
selective pressure from vaccines. However, regular monitoring, surveillance and full 
genome sequence analysis will further help to discover the exact places of mutations, and 
will provide the possible regions of antigenic variation in canine parvovirus. 
From the study, it may be concluded that canine parvovirus-2 variants may represent a 
potential threat to canine populations, thus warranting efforts to increase epidemiological 
monitoring and surveillance, along with the necessary measures to control this disease in 
canine population and to assess the effi cacy of the current vaccines.
_______
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SAŽETAK
Pasji parvovirus važan je uzročnik hemoragijskog gastroenteritisa u odraslih pasa i miokarditisa u štenadi. 
U ovom su istraživanju djelomično analizirane nukleotidne sekvencije gena VP1/VP2 izolata pasjeg parvovirusa 
iz Mathure u Indiji sa svrhom da se njihova fi logenetska svojstva usporede s drugim izolatima toga virusa. Od 
100 uzoraka izdvojenih iz pasa s gastroenteritisom odnosno s povraćanjem i proljevom, 63 su bila pozitivna 
na pasji parvovirus 2 upotrebom lančane reakcije polimerazom. Od toga je osam uzoraka uzeto za određivanje 
njihova nukleotidnog slijeda. Filogenetska analiza je pokazala da varijante pasjeg parvovirusa nisu bile samo 
međusobno usko srodne, već su s neznatnim skretanjem bile srodne i sa svojim predcima, kao što je virus 
enteritisa američke vidrice, što upućuje na njihove neznatne razlike od njihova nastanka. Može se zaključiti 
da varijante pasjeg parvovirusa 2 predstavljaju moguću prijetnju za populaciju pasa. Potrebno je uložiti više 
napora u smjeru epizootioloških istraživanja i donošenja mjera nadzora te kontrole ove zarazne bolesti zajedno 
s naporima za procjenu učinkovitosti postojećih cjepiva.
Ključne riječi: pasji parvovirus, pas, molekularna obilježja, lančana reakcija polimerazom, fi logenetska 
analiza________________________________________________________________________________________
